To Compare: The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics. Concept introduction: Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Question

Want to see more full solutions like this?

Answer 1

Question

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.

Conclusion

Thus, the coagulation modifiers are responsible for promoting or preventing the formation of blood clots.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Students have asked these similar questions

DaVita Dietitian Reference Manual Module 7- Adequacy of Hemodialysis CASE STUDIES Case 1 David was diagnosed with chronic kidney disease a year ago, and now needs hemodialysis. At his first treatment, the nurse hooks up the bloodlines to an access in David's chest. He tells her that he had surgery on his arm three months ago so it can be used for dialysis eventually. 1. What type of access does David have for the initial treatment? 2. Is David's arm access most likely a graft or fistula? 3. What possible reasons prevent use of a fistula or graft for the first dialysis treatment? Case 2 Ramon, a hemodialysis patient for six years, has lost 1.5 kg over the past six weeks. He denies nausea or vomiting, but does admit to eating less at meals and skipping dinner some days. Current dialysis prescription is: 3 1/2 hours (210 minutes), 3 times a week, ASAHI 1050S, APS dialyzer, dialysis flow rate 800 ml/min, blood flow rate 400 ml/min. Monthly bloodwork is as follows: Date K PO4 Pre-BUN…

DaVita Dietitian Reference Manual Module 7 - Adequacy of Hemodialysis REVIEW QUESTIONS True False 1. 27 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. Urea Reduction Ratio is a more accurate measurement of dialysis adequacy than Urea Kinetic Modeling. A fistula is the preferred type of vascular access. In the formula Kt/V, the V represents volume of total body water in which urea is distributed. In the formula Kt/V, time is measured in 15-minute increments, so 220 minutes would be rounded off to the nearest quarter hour. The DaVita minimum goal for adequacy is a spKt/V≥ 1.0. A measured height and accurate dry weight are required to obtain an accurate Kt/V result. A very low post BUN result usually means the patient is not eating enough protein. KRU is a measure of residual urea clearance by the patient's kidney, requiring a 24-hour urine collection. The Kt/V Delivered (single pool) is the value used for determining adequacy and comparing outcomes in DaVita facilities. Catheters are…

DaVita Dietitian Reference Manual Module 7 - Adequacy of Hemodialysis Case 3 Beverly's monthly adequacy of dialysis results came back lower than usual. Her Kt/V is 1.13. Flow sheet data reveals the following: Prescribed BFR 400, patient ran BFR 325 during treatment Blood pressure dropped to 72/58 during treatment, so UFR was turned off. Dry weight 65 kg, pre dialysis weight 69 kg, post dialysis weight 66.5 kg 1. What are DaVita's goals for Kt/V? 2. What is your impression of why the Kt/V is low? 3. What additional information would help in determining why Beverly's adequacy results were below goal?

Answer 2

Question

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.

Conclusion

Thus, the coagulation modifiers are responsible for promoting or preventing the formation of blood clots.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Answer 3

Question

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.

Conclusion

Thus, the coagulation modifiers are responsible for promoting or preventing the formation of blood clots.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Answer 4

Question

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.

Conclusion

Thus, the coagulation modifiers are responsible for promoting or preventing the formation of blood clots.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Answer 5

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.

Conclusion

Thus, the coagulation modifiers are responsible for promoting or preventing the formation of blood clots.

Answer 6

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.

Conclusion

Thus, the coagulation modifiers are responsible for promoting or preventing the formation of blood clots.

Answer 7

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Answer 8

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.